Attached files

file filename
EX-99.1 - SLIDE SHOW PRESENTATION - Alliqua BioMedical, Inc.alqa_ex991.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
_________________
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
_________________
 
Date of Report (Date of earliest event reported):  January 7, 2013
 
   
Alliqua, Inc.
   
   
(Exact Name of Registrant as Specified in its Charter)
   
 
Florida   000-29819   58-2349413
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)
 
850 Third Avenue
Suite 1801
New York, New York
 
10022
(Address of principal executive offices)
 
(Zip Code)

Registrant’s telephone number, including area code: (646) 218-1450
 
 
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c))
 


 
 

 
ITEM 8.01  OTHER EVENTS.

On January 7, 2013, James Sapirstein, President and CEO, of Alliqua, Inc. (the “Company”) presented an overview of the Company’s business and recent developments at Biotech Showcase 2013, held January 7-9, 2013, at the Parc 55 Wyndham Union Square Hotel in San Francisco, California.  A copy of the presentation is attached as Exhibit 99.1 to this report.

ITEM 9.01  FINANCIAL STATEMENTS AND EXHIBITS.

(d)           Exhibits

Exhibit Number
 
Description
     
 
Slide show presentation dated January 7, 2013.
 
 
2

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
  ALLIQUA, INC.  
       
Dated: January 9, 2013
By:
/s/ Steven Berger  
    Name: Steven Berger  
    Title:   Chief Financial Officer  

      
 
3

 
 
EXHIBIT INDEX
 
Exhibit Number
 
Description
     
 
Slide show presentation dated January 7, 2013.
 
 
 
4